Our studies also suggest that oncogenic KRAS signaling is sufficient to induce at least a subset of the intrinsic ISG signatures that are observed across many cancers and cancer cells lines with ADAR dependencies (Gannon et al., 2018; Liu et al., 2019). The gene discussed is KRAS; the disease is cancer.